The theory centers on the stress hormone CRH (corticotropin-releasing hormone) and its two receptors, CRH1 and CRH2. These receptors are involved in the body’s response to stress, with CRH1 linked to energy mobilization and CRH2 associated with managing excess energy. The dysregulation of these receptors forms the basis of anorexia and bulimia.

The theory posits that in anorexia, excessive activation of the CRH2 receptor triggers a biological response that suppresses appetite. This response is amplified by serotonin activity in the gut, leading to nausea, a reduced desire to eat, and even a tendency to vomit. These symptoms, commonly seen in anorexia patients, are explained as biological effects rather than purely psychological behaviors.

In contrast, bulimia is associated with the overactivation of the CRH1 receptor, which drives an unrelenting urge to eat. This leads to binge eating episodes, followed by attempts to purge, often as a way to counteract the distress caused by overeating. Interestingly, the theory highlights that more than half of anorexia patients also experience binge eating, suggesting fluctuations in CRH activity contribute to the overlap of symptoms.

The author emphasizes the importance of addressing the biological underpinnings of these conditions for effective treatment. Reducing the synthesis of CRH could provide a direct approach to alleviating symptoms. While this has not yet been attempted, the author argues it is feasible with current pharmaceutical techniques. Alternatively, drugs targeting serotonin or suppressing gut-related nausea could offer symptom relief for anorexia patients.

For bulimia, the challenge lies in modulating CRH1 activity without exacerbating symptoms of anorexia. The author suggests focusing on balancing CRH receptor activity rather than targeting one receptor in isolation. Such precision medicine approaches could prevent the oscillation between anorexic and bulimic states observed in some patients.

The theory also calls for systematic studies to validate these hypotheses. Measuring CRH levels and receptor activity in patients could establish a clearer link between stress pathways and eating disorders. Additionally, investigating the role of serotonin and other gut-related hormones could provide further insights into the biological mechanisms at play.

In conclusion, the author’s theory reframes anorexia and bulimia as disorders driven by stress hormone dysregulation. This perspective shifts the focus from purely psychological explanations to a more integrated biological model. By targeting the underlying biological processes, this approach holds promise for developing more effective treatments and improving outcomes for individuals with these challenging conditions.